ALZCHEM GROUP AG AlzChem Group AG: Strong result - EBITDA significantly, sales slightly above forecast for fiscal year 2020
Transparency directive : regulatory news
|
DGAP-Ad-hoc: AlzChem Group AG / Key word(s): Change in Forecast Trostberg, January 14, 2021 - After an extremely positive business performance at the end of the year, AlzChem Group AG will close fiscal year 2020 with sales slightly above and adjusted EBITDA significantly above the most recent forecast. The company now expects to generate slightly higher consolidated sales of approximately EUR 379 million in fiscal year 2020 compared to the previous year (2019: EUR 376.1 million; last forecast: stable to slightly declining). Adjusted EBITDA will increase significantly to at least EUR 53 million (2019: EUR 50.1 million; last forecast: stable to moderately declining). The reasons for the very positive development are the recovery of the overall markets, in particular the strong increase in demand from the pharmaceutical industry and the automotive sector. The above figures are preliminary. The final results for fiscal year 2020 will be announced on March 19, 2021.
14-Jan-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | AlzChem Group AG |
| Dr.-Albert-Frank-Str. 32 | |
| 83308 Trostberg | |
| Germany | |
| Phone: | +498621862888 |
| Fax: | +49862186502888 |
| E-mail: | ir@alzchem.com |
| Internet: | www.alzchem.com |
| ISIN: | DE000A2YNT30 |
| WKN: | A2YNT3 |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Stuttgart |
| EQS News ID: | 1160618 |
| End of Announcement | DGAP News Service |
|
|
1160618 14-Jan-2021 CET/CEST